Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Baxter
Harvard Business School
UBS
Moodys
Chinese Patent Office
Merck
Citi
Daiichi Sankyo

Generated: April 21, 2018

DrugPatentWatch Database Preview

Claims for Patent: 8,367,605

« Back to Dashboard

Summary for Patent: 8,367,605
Title:Copolymer-1 improvements in compositions of copolymers
Abstract: The present invention relates to an improved composition of copolymer-1 comprising copolymer-1 substantially free of species having a molecular weight of over 40 kilodaltons.
Inventor(s): Konfino; Eliezer (Ramat Gan, IL), Sela; Michael (Rehovot, IL), Teitelbaum; Dvora (Rehovot, IL), Arnon; Ruth (Rehovot, IL)
Assignee: Yeda Research and Development Co. Ltd. (Rehovot, IL)
Application Number:13/244,737
Patent Claims: 1. A copolymer-1 composition comprising a mixture of copolymers of alanine, glutamic acid, lysine and tyrosine, in a molar ratio of approximately 6:2:5:1, respectively, the copolymer species in the mixture being non-uniform with respect to molecular weight and sequence, which is synthesized by polymerization of suitably protected amino acid carboxyanhydrides, wherein less than 5% of the copolymers have a molecular weight above 40 kDa, and wherein the composition is suitable for treating multiple sclerosis.

2. The copolymer-1 composition of claim 1, wherein less than 2.5% of the copolymers have a molecular weight above 40 kDa.

3. The copolymer-1 composition of claim 1, wherein the mixture of copolymers is synthesized by polymerization of N-carboxyanhydrides of alanine, tyrosine, 7-benzyl glutamate and e-N-trifluoroacetyllysine.

4. The copolymer-1 composition of claim 3, wherein less than 2.5% of the copolymers have a molecular weight above 40 kDa.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Mallinckrodt
UBS
Express Scripts
US Army
Cantor Fitzgerald
Cipla
McKinsey
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.